In This Section

Home / Learn / Cancer Types / Skin Cancer

Skin Cancer

The most common form of cancer diagnosed in the US, skin cancer is on the rise. This increase is likely due to a combination of factors, including heightened awareness and screening, better detection, increased longevity, and more sun exposure.

Non-melanoma skin cancers (NMSCs), including basal cell and squamous cell carcinomas, affect more than 3 million Americans a year. While basal cell carcinoma is the more common of these cancers, both rarely spread to other parts of the body, and they are curable when detected early and treated appropriately.

Although far less common, melanoma is much more likely to metastasize. While only one percent of skin cancers are melanomas, this type of cancer is responsible for the majority of skin cancer deaths.

Advanced Non-Melanoma Skin Cancers

To help community cancer centers better diagnose and treat cutaneous NMSCs, this project aims to engage all members of the multidisciplinary cancer care team as well as non-oncology specialists to collectively address the need for earlier detection and patient referrals.
Learn More

Featured Publication

Multidisciplinary Advanced Cutaneous Squamous Cell Carcinoma Care
This publication maps out effective practices in multidisciplinary cSCC management. Included are three care models from regionally diverse cancer programs located in areas of high cSCC prevalence.

On-Demand Webinars

Multidisciplinary Advanced Cutaneous Squamous Cell Carcinoma Care (Two-Part Series)

The ACCC Multidisciplinary Advanced Cutaneous Squamous Cell Carcinoma (cSCC) Care education project series is designed to support the cancer care team in diagnosing, testing, and treating patients with advanced cSCC.

This two-part series includes webinars developed in conjunction with the multidisciplinary care team who have deep expertise in caring for patients with cSCC as well as high-risk non-melanoma skin cancers.


From Oncology Issues

  • 9 Steps to Hosting Your Own Skin Cancer Screening
  • Developing Skin Cancer Prevention Initiatives for the Whole Family
    By Debra DeNitto, BS
    In 2016, Valley Health, a not-for-profit healthcare system serving patients in Maryland, Virginia, and West Virginia, partnered with a local dermatology office and various community and state stakeholders on a common goal to educate our community about smart sun protection decisions and the importance of skin cancer screenings.
  • Skin Cancer Screening Business Model
    Skin Cancer Screening Business Model
  • Patient-Specific Therapeutic Vaccines for Metastatic Melanoma
    Robert O. Dillman, MD
    The only standard treatments for metastatic melanoma that have been associated with long-term overall survival (OS) are surgical resection, and immunotherapies that include the immune-stimulating cytokine interleukin-2 (IL2), the anticytotoxic T lymphocyte antigen-4 (CTLA-4) monoclonal antibody ipilimumab, and the anti-programmed death 1 (PD1) monoclonal antibodies nivolumab and pembrolizumab (aka lambrolizumab).
  • Stop Cancer Before It Starts!
    Melanie Gonzales, MSPH, MCHES, and Vicky Jekich, CMP
    While young people across the U.S. are able to access more information through technology with greater speed, they may be misinformed or lack understanding of how unhealthy behaviors can put their health at risk.
  • Fox Chase Cancer Center Care Connect
    Kelly Filchner, MSN, RN, OCN, CCRC, and Alan Howald, BS
    Fox Chase Cancer Center, Philadelphia, Pa., committed resources to develop a program to improve communication and education between oncology and primary care, and improve overall survivorship care.